NIH #3R44CA126080-03S1
PhosphoSite. and the Phosphoproteome of Cancer
- Amount
- $150K
- Period
- 2009-09-30 → 2011-09-29
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at CELL SIGNALING TECHNOLOGY, INC.
Monoclonal and Polyclonal Antibodies Research · Radiology, Nuclear Medicine and Imaging
13 total · 0 active
NIH #3R44CA126080-03S1
Awarded at CELL SIGNALING TECHNOLOGY, INC.
NIH #5R44CA126080-03
Awarded at CELL SIGNALING TECHNOLOGY, INC.
NIH #4R44CA126080-02
Awarded at CELL SIGNALING TECHNOLOGY, INC.
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
The intrinsic substrate specificity of the human tyrosine kinome
Nature · 2024-05-08 · 143 citations
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication
Science Signaling · 2022-10-25 · 97 citations
SRSF protein kinases 1 and 2 are essential host factors for human coronaviruses including SARS-CoV-2Preprint
2020-08-15 · 38 citations
bioRxiv (Cold Spring Harbor Laboratory) · 2020-08-14 · 63 citations